Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1764-1768
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1764
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1764
Figure 1 Pathological changes of liver in each group.
A: Liver tissue of normal group (HE ×100); B: Liver tissue of model group (HE ×100); C: Liver tissue of matrine group (matrine 13.5 mg/kg, HE ×100); D: Liver tissue of RF group (40.5 mg/kg RF, HE ×100); E: Liver tissue of RF group (13.5 mg/kg RF, HE ×100); F: Liver tissue of RF group (4.5 mg/kg RF, HE ×100).
Figure 2 Pathological changes of liver in each group.
A: Liver tissue of normal group (HE ×400); B: Liver tissue of model group (HE ×400); C: Liver tissue of matrine group (matrine 13.5 mg/kg, HE ×400); D: Liver tissue of RF group (40.5 mg/kg RF, HE×400); E: Liver tissue of RF group (13.5 mg/kg RF, HE ×400); F: Liver tissue of RF group (4.5 mg/kg RF, HE ×400).
-
Citation: Xu DH, Mei XT, Chen Y, Li YM, Lv JY, Xu SB. Protective effects of 5,4’-dihydroxy-3’,5’-dimethoxy-7-O-
β -D-glucopyranosyloxy-flavone on experimental hepatic injury. World J Gastroenterol 2005; 11(12): 1764-1768 - URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1764